The trajectory of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key territories has introduced substantial risk . Investors are now facing the effect of generic competition , shrinkin